Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 Jun;43(6):826–831. doi: 10.1038/bjc.1981.121

Elevated levels of prolactin in nulliparous women.

M C Yu, V R Gerkins, B E Henderson, J B Brown, M C Pike
PMCID: PMC2010727  PMID: 7248160

Abstract

Follicular-phase (Day 11) plasma prolactin, and plasma and urinary oestrogen levels of 70 nulliparous nuns were compared with those of 80 of their sisters, of whom 62 were parous. The nuns and their nulliparous sisters did not differ significantly in their prolactin and oestrogen levels. No differences in plasma oestrogens or urinary oestriol ratio were found between the parous and the nulliparous women. However, the mean prolactin level of the nuns and their nulliparous sisters was 35% higher than that of the parous women in the sample taken approximately 1 3/4 h after rising (p less than 0.0005), and 24% higher (P less then 0.01) in the 2nd sample taken 2 h later. The elevation was independent of age, weight, and age at menarché. Age at first full-term pregnancy, at least up to the age of 30, and second or subsequent full-term pregnancies had no further effect on prolactin level. This study suggests that the effect of early first full-term pregnancy in lowering breast cancer risk may be mediated, at least in part, by permanently lowering the level of circulating prolactin.

Full text

PDF
829

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown J. B., Macnaughtan C., Smith M. A., Smyth B. Further observations on the Kober colour and Ittrich fluorescence reactions in the measurement of oestriol, oestrone and oestradiol. J Endocrinol. 1968 Feb;40(2):175–188. doi: 10.1677/joe.0.0400175. [DOI] [PubMed] [Google Scholar]
  2. Cairns J. Mutation selection and the natural history of cancer. Nature. 1975 May 15;255(5505):197–200. doi: 10.1038/255197a0. [DOI] [PubMed] [Google Scholar]
  3. Cole P., MacMahon B., Brown J. B. Oestrogen profiles of parous and nulliparous women. Lancet. 1976 Sep 18;2(7986):596–599. doi: 10.1016/s0140-6736(76)90666-8. [DOI] [PubMed] [Google Scholar]
  4. England P. C., Skinner L. G., Cottrell K. M., Sellwood R. A. Serum oestradiol-17 beta in normal women. Br J Cancer. 1974 Jun;29(6):462–469. doi: 10.1038/bjc.1974.98. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hill P., Wynder E. L., Kumar H., Helman P., Rona G., Kuno K. Prolactin levels in populations at risk for breast cancer. Cancer Res. 1976 Nov;36(11 Pt 1):4102–4106. [PubMed] [Google Scholar]
  6. MacMahon B., Cole P., Brown J. Etiology of human breast cancer: a review. J Natl Cancer Inst. 1973 Jan;50(1):21–42. doi: 10.1093/jnci/50.1.21. [DOI] [PubMed] [Google Scholar]
  7. Malarkey W. B., Schroeder L. L., Stevens V. C., James A. G., Lanese R. R. Disordered nocturnal prolactin regulation in women with breast cancer. Cancer Res. 1977 Dec;37(12):4650–4654. [PubMed] [Google Scholar]
  8. Pike M. C., Casagrande J. T., Brown J. B., Gerkins V., Henderson B. E. Comparison of urinary and plasma hormone levels in daughters of breast cancer patients and controls. J Natl Cancer Inst. 1977 Nov;59(5):1351–1355. doi: 10.1093/jnci/59.5.1351. [DOI] [PubMed] [Google Scholar]
  9. Trichopoulos D., Cole P., Brown J. B., Goldman M. B., MacMahon B. Estrogen profiles of primiparous and nulliparous women in Athens, Greece. J Natl Cancer Inst. 1980 Jul;65(1):43–46. [PubMed] [Google Scholar]
  10. Vekemans M., Robyn C. Influence of age on serum prolactin levels in women and men. Br Med J. 1975 Dec 27;4(5999):738–739. doi: 10.1136/bmj.4.5999.738. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Vekemans M., Robyn C. The influence of exogenous estrogen on the circadian periodicity of circulating prolactin in women. J Clin Endocrinol Metab. 1975 May;40(5):886–889. doi: 10.1210/jcem-40-5-886. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES